Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Feb 8, 2018
    Ad Agency Settles with FTC, Maine Over Allegedly Deceptive Weight-loss Radio Ads
  • Feb 5, 2018
    Journal Article Contends MDD Practice Guideline Developers Had Conflicts of Interest, Insufficient Data
  • Feb 2, 2018
    New York Sues Insys Over ‘Reckless’ Marketing of Subsys
  • Feb 1, 2018
    Aegerion To Pay $40 Million To Resolve Juxtapid Marketing Cases
  • Jan 31, 2018
    District Court Certifies Class in Fax Ad Case
  • Jan 30, 2018
    Advocate of Laser Devices Touted as Treatment for Hundreds of Diseases Pleads Guilty to Federal Charges
  • Jan 29, 2018
    NAD Recommends Three Companies' Claims Be Discontinued, Refers Another to FTC
  • Jan 29, 2018
    State Bills Sanction Off-Label Promotion
  • Jan 27, 2018
    Washington Senate Committee Approves Drug Cost Reporting Bill
  • Jan 24, 2018
    FDA-FTC Issues Warning Letters Over Marketing of Opioid Cessation Products
  • More

Good Clinical Practice

  • Jun 8, 2018
    Survey Finds Trial Subjects Think Sharing Patient-level Data Has More Benefit Than Risk
  • Jun 6, 2018
    Harkonen Denied Rehearing on Conviction
  • Jun 5, 2018
    Draft Guidance Focuses on How to Include Adolescents in Relevant Adult Oncology Trials
  • Jun 1, 2018
    Johnson Writes Gottlieb on FDA Implementation of Federal Right-to-Try Law
  • May 31, 2018
    Number of FDA BIMO Inspections Drops Slightly in FY 2017
  • May 31, 2018
    FDA Provides Guidance on Topical OTC MUsT Studies
  • May 31, 2018
    FDA Issues Final Guidance for Acne Trials
  • May 30, 2018
    Federal Right-to-Try Bill Signed into Law
  • May 29, 2018
    Lack of Subjects Hurting Cancer Cell Therapy Research
  • May 29, 2018
    European Study Finds Fewer Women Meet Eligibility Criteria for Heart Failure Trials
  • More

U.S. Food Labeling

  • May 10,2013
    Third Circuit Upholds Preemption in State-level Consumer Fraud Suit Over Benecol Labeling Claims
  • May 9,2013
    FTC Strikes Out in Effort to Limit Expert Testimony on Substantiation
  • May 9,2013
    FTC Strikes Out in Effort to Limit Expert Testimony on Substantiation
  • May 9,2013
    CSPI Threatens Suit Over Multivitamin Claims, Bayer Blasts Group for Citing Outdated Labels
  • May 2,2013
    Ballot Initiative To Decide Fate of GMO Labeling in Washington State
  • Apr 26,2013
    House and Senate Target GMOs With Twin Bills Mandating Labeling Disclosure for Modified Foods
  • Apr 16,2013
    GMO Labeling Initiatives Gaining Steam in States, Disclosure Bills Pick Up Where Prop. 37 Left Off
  • Apr 10,2013
    Study of Food Label Coloring Suggests Its Easy Being Green
  • Apr 10,2013
    Meat Industry Revising Labels To Simplify Naming Conventions
  • Apr 4,2013
    Trade Group Pushes Self-regulation of Energy Drink Labeling, Issues Proposal on Caffeine Disclosures
  • More

FDA Regulation & Enforcement

  • Mar 11, 2021
    Florida Physician, Clinic Officials Face Multiple Charges for Allegedly Falsifying Clinical Trial Data
  • Mar 9, 2021
    NAD Provides Tips for Influencer Marketing
  • Mar 4, 2021
    Bioventus To Pay More than $3.6 Million To Resolve False Claims Allegations Following Self-Disclosure
  • Mar 4, 2021
    Court: Plaintiffs Failed To Establish State Law Duty of Valve Makers To Report Adverse Events to FDA
  • Mar 4, 2021
    Class Action Suits Call for Labeling and Reduction of Heavy Metals in Baby Foods
  • Mar 3, 2021
    OPDP Researchers Move Ahead with Study of Promotion of Multiple Indications in DTC TV Ads
  • Feb 25, 2021
    Hawaii Court Orders Drug Makers To Pay More Than $834 Million for Withholding Plavix Efficacy Info
  • Feb 19, 2021
    OPDP Issues Two Warning Letters To Start 2021
  • Feb 18, 2021
    FDA May Boost On-site Drug Inspections, Increase Use of Alternative Inspection Tools After GAO Study
  • Feb 18, 2021
    Firms Agree to Discontinue Marketing Claims in Response to NAD Recommendations
  • More

Medical Devices

  • Feb 12, 2016
    Senator Boxer Highlights Cybersecurity Concerns in Letter to Medical Technology CEOs
  • Feb 8, 2016
    Draft Guidance Covers Design Considerations, Premarket Submission Content for Interoperable Devices
  • Feb 6, 2016
    Human Factors Validation Studies Must Be Conducted Before Clinical Studies for Device Combo Products
  • Feb 3, 2016
    FDA: Human Factors Engineering Can Help Device Makers Reduce Risk, Prevent Adverse Events, Recalls
  • Jan 25, 2016
    Final Guidance Recommends Sterilization Information To Include in 510(k) Submissions
  • Jan 20, 2016
    Postmarket Device Cybersecurity Draft Guidance Stresses Information Sharing
  • Jan 14, 2016
    Report: Infections Associated with Duodenoscopes Show Device Safety Monitoring System Is Ineffective
  • Jan 13, 2016
    Court Rejects Argument That All Off-label Uses of Stent Caused Submissions of False Claims
  • Jan 7, 2016
    Court Rejects Latest Qui Tam Complaint, Ending Five-Year False Claims Suit Against Device Firm
  • Jan 6, 2016
    FDA Terminates Audit Report Pilot Program in Anticipation of ‘Fully Operational’ MDSAP
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.